CHOICE OF DRUGS BY A GRADUATOR OF A MEDICAL UNIVERSITY IN INDIVIDUAL STANDARD SITUATIONS OF OUTPATIENT PRACTICE

The article is devoted to the study and analysis of the pharmacotherapeutic competence of the graduates of the medical university on the threshold of the independent medical activity in the primary link of public health. 169 students of the 6th year of the Medical Department of Yevdokimov MGMSU responded in writing to 8 tasks which proposed to name the optimal medicinal products (MP) in a number of standard situations of outpatient practice. The mean median of the selection evaluation was 11 points out of 16 impliable meanings. Each respondent indicated his average academic performance and assessed his/her own confidence in reasonable command of pharmacotherapy – the mean median for these indicators was 3 out of 5 and 6 out of 10 points, respectively. All 3 studied parameters showed a very weak positive relationship between themselves in ρ range from 0.19 to 0.24 for p <0.05. In the separate analysis of these indicators in the subgroups of students with high and average academic performance, no relationship between performance, assessment of drug choice and self-assessment of pharmacotherapeutic competence has been identified. The average assessment of the choice of drugs between these subgroups did not differ either. The data given indicate that the best average academic performance does not guarantee higher competence of respondents in the choice of medicines. The authors recommend purposeful pharmacotherapeutic preparation of students on the graduate course, taking into account the specificity of the forthcoming medical activity

The experience of using acetylsalicylic acid in a comorbid patient with cad and type 2 diabetes

The CVD death rates remain high now. The concurrent course of coronary artery disease (CAD) and diabetes mellitus (DM) has an unfavourable prognosis, requires specific therapy and the use of measures to prevent severe complications. DM sometimes hinders the timely diagnosis of CAD, which in this case is characterized by an atypical course and has no florid symptoms. This often causes serious pathological complications or death. The atherothrombosis forms the basis of pathogenesis of severe conditions. Atherothrombosis is not only a generalized, but also a constantly progressive disease, for which reason it is necessary to carry out both primary and secondary prevention. According to the existing guidelines of European Society of Cardiology and Society of Cardiology of Russian Federation, acetylsalicylic acid (ASA) is recommended at small doses as the first-line drug for the prevention of vascular events in patients with CAD. This article discusses the experience of using ASA according to the conducted studies and in practical medicine by the clinical example of a female patient

Drugs in general medical practice: practical advice for a starting practitioner

The article is intended for starting primary care practitioners and senior students of medical schools. The authors provide the main principles of choosing and prescribing drugs in general medical practice on the ground of personal medical and teaching experience, and modern domestic and foreign literature. Practical advice is provided with up-to-date references to available electronic resources containing important background information on the key issues of modern pharmacotherapy. Reading the presented material will help to avoid making some typical mistakes and enhance the professional competence of a practitioner who starts working in the primary health care

The influence of surgical menopause oncardiovascular and osteoporosis risk factors(clinical observations)

Основным средством коррекции утраченной функции яичников при возникновении хирургической менопаузы (ХМ) в репродуктивном возрасте является заместительная гормональная терапия (ЗГТ). Отдаленные результаты длительного проведения ЗГТ у женщин (10 и более лет ХМ) изучены мало. В клинических наблюдениях сопоставлены данные обследования сердечно-сосудистой системы и минеральной плотности кости двух пациенток с ХМ после тотальной овариоэктомии в зависимости от назначения ЗГТ. Клинические примеры демонстрируют выраженные атеросклеротические изменения сосудов и значительные потери костной массы у пациентки с ХМ, не получавшей ЗГТ, в сравнении с пациенткой, длительно получавшей терапию женскими половыми гормонами